In vitro evaluation of physicochemical-dependent effects of polymeric nanoparticles on their cellular uptake and co-localization using pulmonary calu-3 cell lines

References

• Anderson CF, Grimmett ME, Domalewski CJ, et al. Inhalable nanotherapeutics to improve treatment efficacy for common lung diseases. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020;12(1):e1586. doi: 10.1002/wnan.1586.
   PubMed Web of Science ®Google Scholar
• Osman NM, Sexton DW, Saleem IY. Toxicological assessment of nanoparticle interactions with the pulmonary system. Nanotoxicology. 2020;14(1):21–58. doi: 10.1080/17435390.2019.1661043.
   PubMed Web of Science ®Google Scholar
• Snipstad S, Westrøm S, Mørch Y, et al. Contact-mediated intracellular delivery of hydrophobic drugs from polymeric nanoparticles. Cancer Nanotechnol. 2014;5(1):8. doi: 10.1186/s12645-014-0008-4.
   PubMedGoogle Scholar
• Osman N, Kaneko K, Carini V, et al. Carriers for the targeted delivery of aerosolized macromolecules for pulmonary pathologies. Expert Opin Drug Deliv. 2018;15(8):821–834. doi: 10.1080/17425247.2018.1502267.
   PubMed Web of Science ®Google Scholar
• Essa D, Kondiah PPD, Choonara YE, et al. The design of poly(lactide-co-glycolide) nanocarriers for medical applications. Front Bioeng Biotechnol. 2020;8:48. (doi: 10.3389/fbioe.2020.00048.
   PubMed Web of Science ®Google Scholar
• Swider E, Koshkina O, Tel J, et al. Customizing poly(lactic-co-glycolic acid) particles for biomedical applications. Acta Biomater. 2018;73:38–51. doi: 10.1016/j.actbio.2018.04.006.
   PubMed Web of Science ®Google Scholar
• Mohamed A, Kunda NK, Ross K, et al. Polymeric nanoparticles for the delivery of miRNA to treat chronic obstructive pulmonary disease (COPD). Eur J Pharm Biopharm. 2019;136:1–8. doi: 10.1016/j.ejpb.2019.01.002.
   PubMed Web of Science ®Google Scholar
• Mohamed A, Pekoz AY, Ross K, et al. Pulmonary delivery of nanocomposite microparticles (NCMPs) incorporating miR-146a for treatment of COPD. Int J Pharm. 2019;569:118524. doi: 10.1016/j.ijpharm.2019.118524.
   PubMed Web of Science ®Google Scholar
• Rodrigues TC, Oliveira MLS, Soares-Schanoski A, et al. Mucosal immunization with PspA (pneumococcal surface protein a)-adsorbed nanoparticles targeting the lungs for protection against pneumococcal infection. PLoS One. 2018;13(1):e0191692. doi: 10.1371/journal.pone.0191692.
   PubMed Web of Science ®Google Scholar
• Chakraborty A, Das A, Raha S, et al. Size-dependent apoptotic activity of gold nanoparticles on osteosarcoma cells correlated with SERS signal. J Photochem Photobiol B. 2020;203:111778. doi: 10.1016/j.jphotobiol.2020.111778.
   PubMed Web of Science ®Google Scholar
• Srijampa S, Buddhisa S, Ngernpimai S, et al. Influence of gold nanoparticles with different surface charges on localization and monocyte behavior. Bioconjug Chem. 2020;31(4):1133–1143. doi: 10.1021/acs.bioconjchem.9b00847.
   PubMed Web of Science ®Google Scholar
• Manzanares D, Ceña V. Endocytosis: the nanoparticle and submicron nanocompounds gateway into the cell. Pharmaceutics. 2020;12(4):371. doi: 10.3390/pharmaceutics12040371.
   PubMed Web of Science ®Google Scholar
• Sakagami M. In vitro, ex vivo and in vivo methods of lung absorption for inhaled drugs. Adv Drug Deliv Rev. 2020;161-162:63–74. doi: 10.1016/j.addr.2020.07.025.
   PubMed Web of Science ®Google Scholar
• Otani T, Furuse M. Tight junction structure and function revisited. Trends Cell Biol. 2020;30(12):1014–1817. doi: 10.1016/j.tcb.2020.10.001.
   PubMed Web of Science ®Google Scholar
• Kunda NK, Alfagih IM, Dennison SR, et al. Bovine serum albumin adsorbed PGA-co-PDL nanocarriers for vaccine delivery via dry powder inhalation. Pharm Res. 2015;32(4):1341–1353. doi: 10.1007/s11095-014-1538-5.
   PubMed Web of Science ®Google Scholar
• Alfagih I, Kunda N, Alanazi F, et al. Pulmonary delivery of proteins using nanocomposite microcarriers. J Pharm Sci. 2015;104(12):4386–4398. doi: 10.1002/jps.24681.
   PubMed Web of Science ®Google Scholar
• Tawfeek H, Khidr S, Samy E, et al. Poly(glycerol adipate-co-ω-Pentadecalactone) Spray-Dried microparticles as sustained release carriers for pulmonary delivery. Pharm Res. 2011;28(9):2086–2097. doi: 10.1007/s11095-011-0433-6.
   PubMed Web of Science ®Google Scholar
• Mejia J, Valembois V, Piret J-P, et al. Are stirring and sonication pre-dispersion methods equivalent for in vitro toxi­cology evaluation of SiC and TiC? J Nanopart Res. 2012;14(4):1–18. doi: 10.1007/s11051-012-0815-7.
   PubMed Web of Science ®Google Scholar
• Ehrhardt C, Fiegel J, Fuchs S, et al. Drug absorption by the respiratory mucosa: cell culture models and particulate drug carriers. J Aerosol Med. 2002;15(2):131–139. doi: 10.1089/089426802320282257.
   PubMedGoogle Scholar
• Selby LI, Cortez-Jugo CM, Such GK, et al. Nanoescapology: progress toward understanding the endosomal escape of polymeric nanoparticles. WIREs Nanomed Nanobiotechnol. 2017;9(5):e1452. doi: 10.1002/wnan.1452.
   Google Scholar
• Dos Santos T, Varela J, Lynch I, et al. Effects of transport inhibitors on the cellular uptake of carboxylated polystyrene nanoparticles in different cell lines. PLoS One. 2011;6(9):e24438. doi: 10.1371/journal.pone.0024438.
   PubMed Web of Science ®Google Scholar
• Stentebjerg-Andersen A, Notlevsen IV, Brodin B, et al. Calu-3 cells grown under AIC and LCC conditions: implications for dipeptide uptake and transepithelial transport of substances. Eur J Pharm Biopharm. 2011;78(1):19–26. doi: 10.1016/j.ejpb.2010.12.030.
   PubMed Web of Science ®Google Scholar
• Furubayashi T, Inoue D, Nishiyama N, et al. Comparison of various cell lines and three-Dimensional mucociliary tissue model systems to estimate drug permeability using an in vitro transport study to predict nasal drug absorption in rats. Pharmaceutics. 2020;12(1):79. doi: 10.3390/pharmaceutics12010079.
   PubMed Web of Science ®Google Scholar
• Salomon JJ, Muchitsch VE, Gausterer JC, et al. The cell line NCl-H441 is a useful in vitro model for transport studies of human distal lung epithelial barrier. Mol Pharm. 2014;11(3):995–1006. doi: 10.1021/mp4006535.
   PubMed Web of Science ®Google Scholar
• Kuehn A, Kletting S, de Souza Carvalho-Wodarz C, et al. Human alveolar epithelial cells expressing tight junctions to model the air-blood barrier. 2016;33(3):251–260.
   Google Scholar
• Weiser N, Molenda N, Urbanova K, et al. Paracellular permeability of bronchial epithelium is controlled by CFTR. Cell Physiol Biochem. 2011;28(2):289–296. doi: 10.1159/000331742.
   PubMedGoogle Scholar
• Cárdenas PA, Kratz JM, Hernández A, et al. In vitro intestinal permeability studies, pharmacokinetics and tissue distri­bution of 6-methylcoumarin after oral and intraperitoneal administration in wistar rats. Braz J Pharm Sci. 2017;53(1):1–9. doi: 10.1590/s2175-97902017000116081.
   Web of Science ®Google Scholar
• Moss DM, Liptrott NJ, Curley P, et al. Rilpivirine inhibits drug transporters ABCB1, SLC22A1, and SLC22A2 in vitro. Antimicrob Agents Chemother. 2013;57(11):5612–5618. doi: 10.1128/AAC.01421-13.
   PubMed Web of Science ®Google Scholar
• Bol L, Galas J-C, Hillaireau H, et al. A microdevice for parallelized pulmonary permeability studies. Biomed Microdevices. 2014;16(2):277–285. doi: 10.1007/s10544-013-9831-3.
   PubMed Web of Science ®Google Scholar
• Bessa MJ, Brandão F, Rosário F, et al. Assessing the in vitro toxicity of airborne (nano) particles to the human respiratory system: from basic to advanced models. J Toxicol Environ Health B Crit Rev. 2023;26(2):67–96. doi: 10.1080/10937404.2023.2166638.
   PubMed Web of Science ®Google Scholar
• Graves RA, Ledet GA, Glotser EY, et al. Formulation and evaluation of biodegradable nanoparticles for the oral delivery of fenretinide. Eur J Pharm Sci. 2015;76:1–9. doi: 10.1016/j.ejps.2015.04.024.
   PubMed Web of Science ®Google Scholar
• Mura S, Hillaireau H, Nicolas J, et al. Biodegradable nanoparticles meet the bronchial airway barrier: how surface properties affect their interaction with mucus and epithelial cells. Biomacromolecules. 2011;12(11):4136–4143. doi: 10.1021/bm201226x.
   PubMed Web of Science ®Google Scholar
• Dausend J, Musyanovych A, Dass M, et al. Uptake mechanism of oppositely charged fluorescent nanoparticles in HeLa cells. Macromol Biosci. 2008;8(12):1135–1143. doi: 10.1002/mabi.200800123.
   PubMed Web of Science ®Google Scholar
• Francia V, Montizaan D, Salvati A. Interactions at the cell membrane and pathways of internalization of nano-sized materials for nanomedicine. Beilstein J Nanotechnol. 2020;11(1):338–353. doi: 10.3762/bjnano.11.25.
   PubMedGoogle Scholar
• Zhao J, Stenzel MH. Entry of nanoparticles into cells: the importance of nanoparticle properties. Polym Chem. 2018;9(3):259–272. doi: 10.1039/C7PY01603D.
   Web of Science ®Google Scholar
• Foroozandeh P, Aziz AA. Insight into cellular uptake and intracellular trafficking of nanoparticles. Nanoscale Res Lett. 2018;13(1):339. doi: 10.1186/s11671-018-2728-6.
   PubMed Web of Science ®Google Scholar
• Raudszus B, Mulac D, Langer K. A new preparation strategy for surface modified PLA nanoparticles to enhance uptake by endothelial cells. Int J Pharm. 2018;536(1):211–221. doi: 10.1016/j.ijpharm.2017.11.047.
   PubMedGoogle Scholar
• Kurashina Y, Imashiro C, Hirano M, et al. Enzyme-free release of adhered cells from standard culture dishes using intermittent ultrasonic traveling waves. Commun Biol. 2019;2(1):393. doi: 10.1038/s42003-019-0638-5.
   PubMedGoogle Scholar
• Shin H, Kwak M, Lee TG, et al. Quantifying the level of nanoparticle uptake in mammalian cells using flow cytometry. Nanoscale. 2020;12(29):15743–15751. doi: 10.1039/d0nr01627f.
   PubMed Web of Science ®Google Scholar
• Durán V, Yasar H, Becker J, et al. Preferential uptake of chitosan-coated PLGA nanoparticles by primary human antigen presenting cells. Nanomedicine. 2019;21:102073. doi: 10.1016/j.nano.2019.102073.
   PubMed Web of Science ®Google Scholar
• Mazumdar S, Chitkara D, Mittal A. Exploration and insights into the cellular internalization and intracellular fate of amphiphilic polymeric nanocarriers. Acta Pharm Sin B. 2021;11(4):903–924. doi: 10.1016/j.apsb.2021.02.019.
   PubMed Web of Science ®Google Scholar
• Sahin A, Esendagli G, Yerlikaya F, et al. A small variation in average particle size of PLGA nanoparticles prepared by nanoprecipitation leads to considerable change in nano­particles’ characteristics and efficacy of intracellular delivery. Artif Cells Nanomed Biotechnol. 2017;45(8):1657–1664. doi: 10.1080/21691401.2016.1276924.
   PubMed Web of Science ®Google Scholar
• Uzhytchak M, Smolková B, Lunova M, et al. Lysosomal nanotoxicity: impact of nanomedicines on lysosomal function. Adv Drug Deliv Rev. 2023;197:114828. doi: 10.1016/j.addr.2023.114828.
   PubMed Web of Science ®Google Scholar